Cancer Anorexia - Pipeline Review, H1 2012 New Reporrt
Cancer Anorexia - Pipeline Review, H1 2012, provides an overview of the Cancer Anorexia therapeutic pipeline. This report provides information on the therapeutic development for Cancer Anorexia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cancer Anorexia. 'Cancer Anorexia - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured...
View full press release